Albendazole 200 mg + Ivermectin 1.5 mg/5 ml Oral Suspension (10 ml)

Effectively target and eliminate a wide range of intestinal parasitic worms with this Albendazole and Ivermectin oral suspension. Designed for human use, this broad-spectrum combination targets roundworms, hookworms, whipworms, pinworms, and more by disrupting their metabolism and eradicating them from the body. Formulated in a palatable pineapple flavour and conveniently packaged in a 10 ml PET bottle with a measuring cap for precise dosing.

Albendazole 200 mg + Ivermectin 1.5 mg/5 ml Oral Suspension (10 ml) is an anthelmintic pharmaceutical formulation combining Albendazole, a broad-spectrum antiparasitic medicine, with Ivermectin, an antiparasitic agent used against certain susceptible parasites. This combination may be prescribed for the treatment of selected intestinal worm infections and other parasitic infestations when both active ingredients are appropriate for the diagnosed condition. Albendazole works by interfering with microtubule formation and glucose uptake in susceptible parasitic worms, disrupting their metabolism and survival. Ivermectin acts on specific chloride channels in susceptible parasites, affecting their nerve and muscle function and leading to paralysis and elimination of the parasites. Together, these ingredients provide complementary antiparasitic activity against selected susceptible organisms, although the combination is not effective against every type of worm or parasite. The oral suspension formulation in a 10 ml pack provides a liquid dosage form that may be convenient for patients who have difficulty swallowing tablets. The stated composition should be checked carefully on the product label to confirm whether Albendazole 200 mg and Ivermectin 1.5 mg refer to each 5 ml of suspension or another specified quantity. Possible adverse effects may include abdominal discomfort, nausea, vomiting, diarrhoea, headache, or dizziness. The suitability of this combination depends on the patient's age, body weight, type of parasitic infection, and medical history. Special caution is necessary in young children, pregnant patients, and individuals with liver disease or other significant medical conditions. Albendazole and Ivermectin should be used under appropriate medical supervision, with the dose and duration determined according to the confirmed infection and approved product instructions.